(90 days)
Not Found
Not Found
No
The description focuses on the laser technology and hardware components, with no mention of AI or ML.
No
The device is indicated for hair removal and permanent hair reduction, which are aesthetic rather than therapeutic purposes.
No
The device is indicated for hair removal and permanent hair reduction, which are therapeutic procedures, not diagnostic.
No
The device description explicitly details hardware components such as a laser diode, power supply, PC-104, microcontroller, fiber optics delivery system, handpiece, and external TE chiller. This indicates it is a hardware-based medical device, not software-only.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "hair removal and permanent hair reduction in dermatology and plastic surgery procedures." This is a therapeutic or aesthetic procedure performed directly on the patient's body.
- Device Description: The device is a laser system that delivers light to the body. This is a physical intervention, not a test performed on a sample taken from the body.
- Lack of IVD Characteristics: IVD devices are used to examine specimens (like blood, urine, tissue) taken from the human body to provide information for diagnosis, monitoring, or screening. This device does not involve the analysis of any such specimens.
The device described is a therapeutic or aesthetic medical device used for a physical procedure on the patient.
N/A
Intended Use / Indications for Use
The Device is indicated for hair removal and permanent hair reduction in dermatology and plastic surgery procedures.
Product codes (comma separated list FDA assigned to the subject device)
GEX
Device Description
The F1 Diode Laser System delivers a pulsed infrared laser light at a wavelength of 810 nanometers. The laser consists of several interconnected sections: The cabinet which houses the laser diode, the power supply, the PC-104, and the microcontroller, the umbilical which houses the fiber optics delivery system, and the handpiece and the external TE chiller.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
30235
APR 2 3 2003
510(K) SUMMARY
Date: 21 January 2003
Submission Correspondent: Emergo Group, Inc.
Address: 1684 East Gude Drive, Suite 202 Rockville, MD 20850
(301) 762-2828 Phone: Fax: (301) 762-4043
Contact: Mr. Rene van de Zande
| Trade Name: | F1 Diode Laser System |
|---|---|
| Common Name: | Pulsed Diode Laser |
| Classification: | Laser Instrument, Surgical, Powered: GEX |
Description: The F1 Diode Laser System delivers a pulsed infrared laser light at a wavelength of 810 nanometers. The laser consists of several interconnected sections: The cabinet which houses the laser diode, the power supply, the PC-104, and the microcontroller, the umbilical which houses the fiber optics delivery system, and the handpiece and the external TE chiller.
Intended Use: The Device is indicated for hair removal and permanent hair reduction in dermatology and plastic surgery procedures.
Predicate Devices: The predicate devices referenced in this submission are: the Opus Medical F1 Diode Laser System for the existing indication, the Lumenis LightSheer™ Pulsed Diode Arrav Laser System, Iridex Iriderm Apex 800, and the Altus Medical Modified CoolClide Aesthetic Lasers.
Summary and Conclusions Regarding Substantial Equivalence:
By definition, a device is substantially equivalent when the device has the same intended use and the same technological characteristics as the predicate device, or has the same intended use and different technological characteristics, but it can be demonstrated that the device is as safe and effective as the predicate device and the new device does not raise different questions regarding safety and effectiveness as compared to the predicate device.
The differences between theF1 Diode Laser System and the predicate devices cited do not raise any different questions regarding safety and effectiveness. The differences in the technological characteristics are minimal. Furthermore, the subject of this submission is identical to the previously cleared F1 Diode Laser System with the exception of the indications for use. The new indications are nearly identical to the indications of two of the predicate devices.
The device, as designed, is as safe and effective as the predicate devices, and the device is substantially equivalent to the referenced predicate devices.
000003
1
Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a circular design with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized profiles facing to the right.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 2 3 2003
APR 23 20
Opus Medical, Inc. c/o Ms. Rene van de Zande President Emergo Group, Inc. 1684 East Gude Drive, Suite 202 Rockville, Maryland 20850
Re: K030235
Trade/Device Name: F1 Diode Laser System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: January 22, 2003
Dear Ms. van de Zande:
Received: January 23, 2003
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Ms. Rene van de Zande
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
for Mark N. Milliken
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Page 1 of 1
510(k) Number (if known): _/